Renoprotective effect of erythropoietin in rats subjected to ischemia/reperfusion injury: Gender differences

Surgery

Volumn 150, Issue 1, 2011, Pages 39-47

  Prókai, Ágnes ^a   Fekete, Andrea ^a   Bánki, Nóra Fanni ^a   Müller, Veronika ^a   Vér, Ágota ^a   Degrell, Péter ^b   Rusai, Krisztina ^a   Wagner, László ^a   Vannay, Ádám ^a   Rosta, Máté ^a   Heemann, Uwe ^c   Langer, Róbert M ^a   Tulassay, Tivadar ^a,d   Reusz, György ^a   Szabó, Attila J ^a,d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CREATININE; HEAT SHOCK PROTEIN 72; RECOMBINANT ERYTHROPOIETIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ENZYME SUBUNIT; FEMALE; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; KAPLAN MEIER METHOD; KIDNEY; KIDNEY ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RENAL PROTECTION; REPERFUSION INJURY; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

ANIMALS; BLOOD UREA NITROGEN; CREATININE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HSP72 HEAT-SHOCK PROTEINS; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; RATS; RATS, WISTAR; REPERFUSION INJURY; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 79959341907     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.02.019     Document Type: Article

References (41)

1. Müller V, Losonczy G, Heemann U, Vannay A, Fekete A, Reusz G, et al. Sexual dimorphism in renal ischemiareperfusion injury in rats: possible role of endothelin. Kidney Int 2002;62:1364-71.
2. Fekete A, Vannay A, Vér A, Vásárhelyi B, Müller V, Ouyang N, et al. Sex differences in the alterations of Na(+), K(+)- ATPase following ischemia-reperfusion injury in the rat kidney. J Physiol 2004;555:471-80. (Pubitemid 38380004)
3. Fekete A, Vannay A, Vér A, Rusai K, Müller V, Reusz G, et al. Sex differences in heat shock protein 72 expression and localization in rats following renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2006;291:806-11.
4. Erdely A, Greenfeld Z, Wagner L, Baylis C. Sexual dimorphism in the aging kidney: effects on injury and nitric oxide system. Kidney Int 2003;63:1021-6. (Pubitemid 36315580)
5. Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990;248:378-81.
6. Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci 2003;100:4802-6. (Pubitemid 36457809)
7. Tang YD, Hasan F, Giordano FJ, Pfau S, Rinder HM, Katz SD. Effects of recombinant human erythropoietin on platelet activation in acute myocardial infarction: results of a double-blind, placebo-controlled, randomized trial. Am Heart J 2009;158:941-7.
8. Yilmaz S, Ates E, Tokyol C, Pehlivan T, Erkasap S, Koken T. The protective effect of erythropoietin on ischemia/reperfusion injury of liver. HPB (Oxford) 2004;6:169-73. (Pubitemid 39248177)
9. Schmeding M, Rademacher S, Boas-Knoop S, Roecken C, Lendeckel U, Neuhaus P, et al. rHuEPo reduces ischemia-reperfusion injury and improves survival after transplantation of fatty livers in rats. Transplantation 2010;27:161-8.
10. Chatterjee PK. Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 2007;376:1-43. (Pubitemid 350161567)
11. Vesey DA, Cheung C, Pat B, Endre Z, Gobé G, Johnson DW. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004;19:348-55. (Pubitemid 38195983)
12. RusaiK, Prókai A, Szebeni B, Fekete A, Treszl A, Vannay A, et al. Role of serum and glucocorticoid-regulated kinase-1 in the protective effects of erythropoietin during renal ischemia/reperfusion injury. Biochem Pharmacol 2010;79:1173-81.
13. Bonventre JV. Mechanisms of ischemic acute renal failure. Kidney Int 1993;43:1160-78. (Pubitemid 23137105)
14. Paller MS. The cell biology of reperfusion injury in the kidney. J Investig Med 1994;42:632-9.
15. Weight SC, Bell PR, Nicholson ML. Renal ischemiareperfusion injury. Br J Surg 2004;83:162-70.
16. Versteilen AM, Di Maggio F, Leemreis JR, Groeneveld AB, Musters RJ, Sipkema P. Molecular mechanisms of acute renal failure following ischemia/reperfusion. Int J Artif Organs 2004;27:1019-29.
17. Xu B, Dong GH, Liu H, Wang YQ, Wu HW, Jing H. Recombinant human erythropoietin pretreatment attenuates myocardial infarct size: a possible mechanism involves heat shock Protein 70 and attenuation of nuclear factor-kappaB. Ann Clin Lab Sci 2005;35:161-8. (Pubitemid 40677109)
18. Yang CW, Li C, Jung JY, Shin SJ, Choi BS, Lim SW, et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 2003;17:1754-5.
19. Skou JC, Esmann M. The Na, K-ATPase. J Bioenerg Biomembr 1992;24:249-61.
20. Patel NS, Sharples EJ, Cuzzocrea S, Chatterjee PK, Britti D, Yaqoob MM, et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 2004;66:983-9. (Pubitemid 39121002)
21. Kiris I, Kapan S, Kilbas A, Yilmaz N, Altuntaş I, Karahan N, et al. The protective effect of erythropoietin on renal injury induced by abdominal aortic-ischemia-reperfusion in rats. J Surg Res 2008;149:206-13.
22. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004;364:1814-27. (Pubitemid 39488068)
23. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci 1998;95:4635-40.
24. Nemoto T, Yokota N, Keane WF, Rabb H. Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. Kidney Int 2001;59:246-51. (Pubitemid 32055232)
25. Johnson DW, Pat B, Vesey DA, Guan Z, Endre Z, Gobe GC. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004;19:348-55. (Pubitemid 38195983)
26. Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004;15:2115-24. (Pubitemid 39031350)
27. Gong H, Wang W, Kwon TH, Jonassen T, Li C, Ring T, et al. EPO and alpha-MSH prevent ischemia/reperfusioninduced down-regulation of AQPs and sodium transporters in rat kidney. Kidney Int 2004;66:683-95. (Pubitemid 38982012)
28. Hale SL, Sesti C, Kloner RA. Administration of erythropoietin fails to improve long-term healing or cardiac function after myocardial infarction in the rat. J Cardiovasc Pharmacol 2005;46:211-5. (Pubitemid 41060214)
29. Kumagai J, Yorioka N, Kawanishi H, Moriishi M, Komiya Y, Asakimori Y, et al. Relationship between erythropoietin and chronic heart failure in patients on chronic hemodialysis. J Am Soc Nephrol 1999;10:2407-11. (Pubitemid 29501476)
30. Pequignot JM, Spielvogel H, Caceres E, Rodriguez A, Semporé B, Pequignot J, et al. Influence of gender and endogenous sex steroids on catecholaminergic structures involved in physiological adaptation to hypoxia. Pflugers Arch 1997;433:580-6. (Pubitemid 27093118)
31. Ifudu O, Uribarri J, Rajwani I, Vlacich V, Reydel K, Delosreyes G, et al. Gender modulates responsiveness to recombinant erythropoietin. Am J Kidney Dis 2001;38:518-22. (Pubitemid 32803062)
32. Breggia AC, Wojchowski DM, Himmelfarb J. JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells. Am J Physiol Renal Physiol 2008;295:1689-95.
33. Tsuji-Takayama K, Otani T, Inoue T, Nakamura S, Motoda R, Kibata M, et al. Erythropoietin induces sustained phosphorylation of STAT5 in primitive but not definitive erythrocytes generated from mouse embryonic stem cells. Exp Hematol 2006;34:1323-32. (Pubitemid 44374840)
34. Madamanchi NR, Li S, Patterson C, Runge MS. Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway. Arterioscler Thromb Vasc Biol 2001;21:321-6. (Pubitemid 32201173)
35. Choi HK, Waxman DJ. Plasma growth hormone pulse activation of hepatic JAK-STAT5 signaling: developmental regulation and role in male-specific liver gene expression. Endocrinology 2000;141:3245-55. (Pubitemid 32269012)
36. Molitoris BA, Dahl R, Geerdes A. Cytoskeleton disruption and apical redistribution of proximal tubule Na(+)-K(+)- ATPase during ischemia. Am J Physiol Renal Physiol 1992;263:488-95.
37. Kwon TH, Frøkiaer J, Han JS, Knepper MA, Nielsen S. Decreased abundance of major Na(+) transporters in kidneys of rats with ischemia-induced acute renal failure. Am J Physiol Renal Physiol 2000;278:925-39.
38. Aufricht C, Lu E, Thulin G, Kashgarian M, Siegel NJ, Van Why SK. ATP releases HSP-72 from protein aggregates after renal ischemia. Am J Physiol Renal Physiol 1998;274:268-74.
39. Bidmon B, Endemann M, Müller T, Arbeiter K, Herkner K, Aufricht C. HSP-25 and HSP-90 stabilize Na, K-ATPase in cytoskeletal fractions of ischemic rat renal cortex. Kidney Int 2002;62:1620-7.
40. Riordan M, Garg V, Thulin G, Kashgarian M, Siegel NJ. Differential inhibition of HSP72 and HSP25 produces profound impairment of cellular integrity. J Am Soc Nephrol 2004;15:1557-66. (Pubitemid 38679680)
41. Riordan M, Sreedharan R, Wang S, Thulin G, Mann A, Stankewich M, et al. HSP70 binding modulates detachment of Na-K-ATPase following energy deprivation in renal epithelial cells. Am J Physiol Renal Physiol 2005;288:1236-42.